Programme for Monitoring the Impacts of Streptomycin Use in Fire Blight Control

In January 2008, the antibiotic streptomycin was approved for the first time in Switzerland  for treatment of fire blight in orchards. Its use is contingent on various conditions. For example, monitoring is required. The Federal Expert Commission for Biosafety FECB believes it is essential that in addition to studies on the development of resistance in Erwinia amylovora (the causal agent of fire blight), other issues be taken into account as well. In cooperation with various federal agencies, research institutions, and other experts, FECB has therefore launched an interdisciplinary monitoring project. The main purpose of this programme is to gain an objective assessment of the real risks of streptomycin treatments using state of the art scientific methodologies.

Monitoring Programme Streptomycin

Classification of work with genetically modified viral vectors

The recommendation of the FECB on the classification of work with genetically modified viral vectors has been updated and supplemented with two additional commonly used vectors: Adeno-associated and Herpes simplex vectors.

Recommendation viral vectors

Treatment and disposal of waste produced in contained systems

The FECB Recommendation on the treatment and disposal of waste containing genetically modified or pathogenic organisms has also been completely revised and now covers all types of wastes produced in contained systems.

Recommendation on treatment and disposal of waste

The FECB, a permanent federal advisory committee, advises the Federal Council and the federal agencies on the drafting of laws, ordinances, guidelines and recommendations.

It advises the federal and cantonal authorities on the enforcement of these regulations.

It issues statements on licence applications and publishes recommendations on safety measures for studies using genetically modified or pathogenic organisms.